NCT07118475View on ClinicalTrials.gov

Autologous Islet Transplantation for Diabetes

EARLY_PHASE1Not yet recruitingINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

August 18, 2025

Primary Completion Date

May 30, 2027

Study Completion Date

May 30, 2027

Conditions
Diabetes (Insulin-requiring, Type 1 or Type 2)
Interventions
BIOLOGICAL

Autologous islet transplantation

"1. EUS-FNB or surgical procurement of pancreatic tissue~2. In vitro culture of adult pancreatic progenitor~3. In vitroinduction of islets~4. islet transplantation beneath the anterior rectus sheath~5. Post-transplant follow-up"

Trial Locations (1)

200032

Zhongshan Hospital, Shanghai

All Listed Sponsors
lead

Shanghai Zhongshan Hospital

OTHER